BNP Paribas Financial Markets’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$286 Sell
867
-66,086
-99% -$21.8K ﹤0.01% 4447
2025
Q1
$20.9K Sell
66,953
-37,759
-36% -$11.8K ﹤0.01% 3695
2024
Q4
$97.8K Sell
104,712
-115,689
-52% -$108K ﹤0.01% 3324
2024
Q3
$260K Buy
220,401
+215,189
+4,129% +$254K ﹤0.01% 2442
2024
Q2
$4.01K Sell
5,212
-26,950
-84% -$20.7K ﹤0.01% 3102
2024
Q1
$98.1K Buy
32,162
+13,756
+75% +$42K ﹤0.01% 2772
2023
Q4
$59.3K Buy
18,406
+9,756
+113% +$31.4K ﹤0.01% 2811
2023
Q3
$33.2K Sell
8,650
-6,855
-44% -$26.3K ﹤0.01% 2838
2023
Q2
$50.9K Buy
15,505
+15,504
+1,550,400% +$50.9K ﹤0.01% 2845
2023
Q1
$3 Hold
1
﹤0.01% 3201
2022
Q4
$2 Sell
1
-158
-99% -$316 ﹤0.01% 3355
2022
Q3
$293 Sell
159
-914
-85% -$1.68K ﹤0.01% 3861
2022
Q2
$2.31K Buy
1,073
+1,010
+1,603% +$2.17K ﹤0.01% 3224
2022
Q1
$198 Hold
63
﹤0.01% 3505
2021
Q4
$202 Hold
63
﹤0.01% 3496
2021
Q3
$212 Sell
63
-3,371
-98% -$11.3K ﹤0.01% 3347
2021
Q2
$13.4K Sell
3,434
-2,440
-42% -$9.54K ﹤0.01% 3051
2021
Q1
$23.6K Sell
5,874
-2,840
-33% -$11.4K ﹤0.01% 3158
2020
Q4
$20.1K Sell
8,714
-1,048
-11% -$2.42K ﹤0.01% 3191
2020
Q3
$56K Buy
9,762
+8,158
+509% +$46.8K ﹤0.01% 2803
2020
Q2
$11.8K Buy
1,604
+1,534
+2,191% +$11.3K ﹤0.01% 3005
2020
Q1
$209 Hold
70
﹤0.01% 3562
2019
Q4
$290 Sell
70
-1,481
-95% -$6.14K ﹤0.01% 3617
2019
Q3
$5.03K Hold
1,551
﹤0.01% 3629
2019
Q2
$2.87K Sell
1,551
-1,248
-45% -$2.31K ﹤0.01% 3664
2019
Q1
$4.95K Buy
2,799
+2,549
+1,020% +$4.51K ﹤0.01% 3485
2018
Q4
$605 Sell
250
-172
-41% -$416 ﹤0.01% 3306
2018
Q3
$2.39K Hold
422
﹤0.01% 3562
2018
Q2
$3.29K Sell
422
-1,884
-82% -$14.7K ﹤0.01% 3541
2018
Q1
$16.3K Buy
2,306
+1,263
+121% +$8.93K ﹤0.01% 3365
2017
Q4
$10.3K Buy
1,043
+550
+112% +$5.43K ﹤0.01% 3350
2017
Q3
$4.23K Sell
493
-37
-7% -$317 ﹤0.01% 3401
2017
Q2
$5.56K Buy
+530
New +$5.56K ﹤0.01% 3429